Seventy-seven recently isolated bovine ureaplasma (T-mycoplasma) strains were compared by the growth inhibition test with previously reported strains. The complex serological nature of the group was confirmed. Only five of the fresh isolates did not react with antisera to the eight representative bovine strains proposed previously. The suggestion that the serological diversity of the group might be represented by a small number of strains has thus been confirmed. Eleven strains are proposed as representatives of this serological diversity. No common antigens were shown between Ureaplasma urealyticum, the ureaplasmas of human origin, and the bovine isolates.Ureaplasmas, mycoplasmas with urease activity previously called T-mycoplasmas (12), have been isolated from a variety of diseased and apparently nondiseased bovine tissues. The anatomical sites in cattle from which these mycoplasmas have been isolated include eyes, the urogenital tract, and respiratory tract (13). To determine whether some relationship exists between disease and the presence of ureaplasmas, it would be useful to have a means of serologically identifying strains. Reported studies (5, 6, 9) indicate that bovine ureaplasmas are serologically heterogeneous. However, it has been suggested that the serological diversity of the group could be represented by a small number of strains which possess between them the spectrum of antigens synthesized by the group (6). To test this suggestion and to study further the serology of the bovine ureaplasmas, a number of fresh isolates were collected and examined to determine how many of them showed serological cross-reactions with the eight bovine strains previously put forward as representing the group.
MATERIALS AND METHODS
Media.The broth used to culture ureaplasmas, designated U4, consisted of Hanks balanced salt solution (Wellcome, Beckenham, England) (lox concentrate), 4 ml , Hartley digest broth, 20 ml; fetal calf serum (Flow Laboratories, Irvine, Calif.), 15 ml; yeast extract (Distillers Co., Morden, England) (25% [wt/vol] aqueous extract), 10 ml; 1% phenol red, 0.2 ml, 20% urea, 0.25 ml , 5% thallium acetate, 0.5 ml; magnesium sulfate (250 pg/ml), 1 ml; benzylpenicillin (Glaxo Ltd., Greenford, England) (200,000 U/ml), 0.5 ml. Glass-distilled double-deionized water was added to bring the volume to 100 ml, and the pH was adjusted to 6.0 to 6.2 by the addition of N-hydrochloric acid.The solid medium consisted of: Hanks buffered salt solution (lox concentrate), 4 ml, agarose (Miles Labs, Slough, England), 0.8 g; N-2-hydroxyethyl piperazine-N'-2-ethanesulfonic acid (Sigma Chemical Co., St.Louis, Mo.), 1.19 g; Hartley broth, 20 d, glass-distilled water, 44 ml. This mixture was sterilized by autoclaving at 10 lb/in2 for 10 min. After cooling to 56°C the following were added fetal calf serum, 20 ml , 1% putrescine, 1 ml; 0.9% L-cysteine, 1 ml; and yeast extract, penicillin, thallium acetate, and magnesium sulfate at the concentrations noted above. The final pH of the solid medium was about 6.2. Cultures on soli...